Covid-19 Vaccine Janssen
- Name:
Covid-19 Vaccine Janssen
- Company:
Janssen Sciences Ireland
- Active Ingredients:
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 01/04/21

Summary of Product Characteristics last updated on medicines.ie: 1/4/2021
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. Click on this link to Download PDF directly
Janssen Sciences Ireland
Company Products
Items Per Page :
1 - 0 of 62 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 1 April 2021 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 1 April 2021 PIL
Reasons for updating
- New PIL for new product